Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024;21(11):1474-1496.
doi: 10.2174/0115672018267737231116100812.

Dextran-based Drug Delivery Approaches for Lung Diseases: A Review

Affiliations
Review

Dextran-based Drug Delivery Approaches for Lung Diseases: A Review

Manisha Kumari et al. Curr Drug Deliv. 2024.

Abstract

Respiratory disorders, such as tuberculosis, cystic fibrosis, chronic obstructive pulmonary disease, asthma, lung cancer, and pulmonary inflammation, are among the most prevalent ailments in today's world. Dextran, an exopolysaccharide formed by Leuconostoc mesenteroides (slimeproducing bacteria), and its derivatives are investigated for several therapeutic utilities. Dextranbased drug delivery system can become an innovative strategy in the treatment of several respiratory ailments as it offers numerous advantages, such as mucolytic action, airway hydration, antiinflammatory properties, and radioprotective effect as compared to other polysaccharides. Being biocompatible, flexible hydrophilic nature, biodegradable, tasteless, odourless, non-mutagenic, watersoluble and non-toxic edible polymer, dextran-based drug delivery systems have been explored for a wide range of therapeutic applications, especially in lungs and respiratory diseases. The present article comprehensively discusses various derivatives of dextran with their attributes to be considered for drug delivery and extensive therapeutic benefits, with a special emphasis on the armamentarium of dextran-based formulations for the treatment of respiratory disorders and associated pathological conditions. The information provided will act as a platform for formulation scientists as important considerations in designing therapeutic approaches for lung and respiratory diseases. With an emphasis on lung illnesses, this article will offer an in-depth understanding of dextran-based delivery systems in respiratory illnesses.

Keywords: Asthma; COPD; delivery system; dextran; dextran derivatives; respiratory diseases..

PubMed Disclaimer

References

    1. Soriano J.B.; Kendrick P.J.; Paulson K.R.; Gupta V.; Abrams E.M.; Adedoyin R.A.; Adhikari T.B.; Advani S.M.; Agrawal A.; Ahmadian E.; Alahdab F.; Aljunid S.M.; Altirkawi K.A.; Alvis-Guzman N.; Anber N.H.; Andrei C.L.; Anjomshoa M.; Ansari F.; Antó J.M.; Arabloo J.; Athari S.M.; Athari S.S.; Awoke N.; Badawi A.; Banoub J.A.M.; Bennett D.A.; Bensenor I.M.; Berfield K.S.S.; Bernstein R.S.; Bhattacharyya K.; Bijani A.; Brauer M.; Bukhman G.; Butt Z.A.; Cámera L.A.; Car J.; Carrero J.J.; Carvalho F.; Castañeda-Orjuela C.A.; Choi J-Y.J.; Christopher D.J.; Cohen A.J.; Dandona L.; Dandona R.; Dang A.K.; Daryani A.; de Courten B.; Demeke F.M.; Demoz G.T.; De Neve J-W.; Desai R.; Dharmaratne S.D.; Diaz D.; Douiri A.; Driscoll T.R.; Duken E.E.; Eftekhari A.; Elkout H.; Endries A.Y.; Fadhil I.; Faro A.; Farzadfar F.; Fernandes E.; Filip I.; Fischer F.; Foroutan M.; Garcia-Gordillo M.A.; Gebre A.K.; Gebremedhin K.B.; Gebremeskel G.G.; Gezae K.E.; Ghoshal A.G.; Gill P.S.; Gillum R.F.; Goudarzi H.; Guo Y.; Gupta R.; Hailu G.B.; Hasanzadeh A.; Hassen H.Y.; Hay S.I.; Hoang C.L.; Hole M.K.; Horita N.; Hosgood H.D.; Hostiuc M.; Househ M.; Ilesanmi O.S.; Ilic M.D.; Irvani S.S.N.; Islam S.M.S.; Jakovljevic M.; Jamal A.A.; Jha R.P.; Jonas J.B.; Kabir Z.; Kasaeian A.; Kasahun G.G.; Kassa G.M.; Kefale A.T.; Kengne A.P.; Khader Y.S.; Khafaie M.A.; Khan E.A.; Khan J.; Khubchandani J.; Kim Y-E.; Kim Y.J.; Kisa S.; Kisa A.; Knibbs L.D.; Komaki H.; Koul P.A.; Koyanagi A.; Kumar G.A.; Lan Q.; Lasrado S.; Lauriola P.; La Vecchia C.; Le T.T.; Leigh J.; Levi M.; Li S.; Lopez A.D.; Lotufo P.A.; Madotto F.; Mahotra N.B.; Majdan M.; Majeed A.; Malekzadeh R.; Mamun A.A.; Manafi N.; Manafi F.; Mantovani L.G.; Meharie B.G.; Meles H.G.; Meles G.G.; Menezes R.G.; Mestrovic T.; Miller T.R.; Mini G.K.; Mirrakhimov E.M.; Moazen B.; Mohammad K.A.; Mohammed S.; Mohebi F.; Mokdad A.H.; Molokhia M.; Monasta L.; Moradi M.; Moradi G.; Morawska L.; Mousavi S.M.; Musa K.I.; Mustafa G.; Naderi M.; Naghavi M.; Naik G.; Nair S.; Nangia V.; Nansseu J.R.; Nazari J.; Ndwandwe D.E.; Negoi R.I.; Nguyen T.H.; Nguyen C.T.; Nguyen H.L.T.; Nixon M.R.; Ofori-Asenso R.; Ogbo F.A.; Olagunju A.T.; Olagunju T.O.; Oren E.; Ortiz J.R.; Owolabi M.O.; P A, M.; Pakhale, S.; Pana, A.; Panda-Jonas, S.; Park, E-K.; Pham, H.Q.; Postma, M.J.; Pourjafar, H.; Poustchi, H.; Radfar, A.; Rafiei, A.; Rahim, F.; Rahman, M.H.U.; Rahman, M.A.; Rawaf, S.; Rawaf, D.L.; Rawal, L.; Reiner, R.C., Jr; Reitsma, M.B.; Roever, L.; Ronfani, L.; Roro, E.M.; Roshandel, G.; Rudd, K.E.; Sabde, Y.D.; Sabour, S.; Saddik, B.; Safari, S.; Saleem, K.; Samy, A.M.; Santric-Milicevic, M.M.; Sao Jose, B.P.; Sartorius, B.; Satpathy, M.; Savic, M.; Sawhney, M.; Sepanlou, S.G.; Shaikh, M.A.; Sheikh, A.; Shigematsu, M.; Shirkoohi, R.; Si, S.; Siabani, S.; Singh, V.; Singh, J.A.; Soljak, M.; Somayaji, R.; Soofi, M.; Soyiri, I.N.; Tefera, Y.M.; Temsah, M-H.; Tesfay, B.E.; Thakur, J.S.; Toma, A.T.; Tortajada-Girbés, M.; Tran, K.B.; Tran, B.X.; Tudor Car, L.; Ullah, I.; Vacante, M.; Valdez, P.R.; van Boven, J.F.M.; Vasankari, T.J.; Veisani, Y.; Violante, F.S.; Wagner, G.R.; Westerman, R.; Wolfe, C.D.A.; Wondafrash, D.Z.; Wondmieneh, A.B.; Yonemoto, N.; Yoon, S-J.; Zaidi, Z.; Zamani, M.; Zar, H.J.; Zhang, Y.; Vos, T. Prevalence and attributable health burden of chronic respiratory diseases, 1990-2017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet Respir Med 2020,8(6),585-596 - DOI - PubMed
    1. Gould G.S.; Hurst J.R.; Trofor A.; Alison J.A.; Fox G.; Kulkarni M.M.; Wheelock C.E.; Clarke M.; Kumar R.; Recognising the importance of chronic lung disease: A consensus statement from the Global Alliance for Chronic Diseases (Lung Diseases group). Respir Res 2023,24(1),15 - DOI - PubMed
    1. Ho T.; Cusack R.P.; Chaudhary N.; Satia I.; Kurmi O.P.; Under- and over-diagnosis of COPD: A global perspective. Breathe 2019,15(1),24-35 - DOI - PubMed
    1. Zanjbeel M; Asghar N; Aslam M; Khalid S; Islam F; Raza A; Quality of life of participants with chronic respiratory disease
    1. Varshosaz J.; Dextran conjugates in drug delivery. Expert Opin Drug Deliv 2012,9(5),509-523 - DOI - PubMed

LinkOut - more resources